CFO Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$598K Buy
2,270
+25
+1% +$6.77K 0.49% 60
2025
Q4
$563K Buy
+2,245
New +$596K 0.42% 65

Other funds holding LH

CFO Capital Management's LH Position: Q1 2026 in Review

CFO Capital Management increased its Labcorp (LH) stake by 1.1% in Q1 2026, buying an estimated $6.77K and bringing the position to 2,270 shares worth $598K. The position accounts for 0.49% of the portfolio, ranked #60.

CFO Capital Management first reported a position in LH in Q4 2025 and has held it in 2 quarters since. 1,034 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • CFO Capital Management held 2,270 shares of Labcorp worth $598K as of Q1 2026.
  • CFO Capital Management bought 25 Labcorp shares in Q1 2026, an estimated $6.77K.
  • Labcorp made up 0.49% of CFO Capital Management's portfolio in Q1 2026, its #60 holding.
  • CFO Capital Management first reported a position in Labcorp in Q4 2025 and has held it in 2 quarters since.
  • 1,034 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on CFO Capital Management's 13F filing for Q1 2026, filed 4 May 2026.